TABLE 2.
Overview of some of the most pioneering URT and OM microbiome studies
Focus or OM type | Sample type(s) | Disease-associated bacteriaa | Sequencing method | No. of subjects (country) | Age(s) (mos or as indicated), no. of subjects/group | Reference |
---|---|---|---|---|---|---|
Focus | ||||||
Respiratory microbiota in healthy infants | Nasal swabs | Haemophilus, Streptococcus | 454 sequencing, V5-V7 region | 60 (The Netherlands) | 1.5–24 | 41 |
Nasal aspirates | Moraxella, Streptococcus, Haemophilus | Illumina MiSeq, V4 region | 234 (Australia) | 2–12 | 52 | |
OM type | ||||||
AOM | Nasal swabs | S. pneumoniae, Haemophilus, Rothia, Actinomyces | 454 sequencing, V1-V2 region | 108 (USA) | 6–78 | 59 |
Nasal swabs | Moraxellaceae, Streptococcaceae, Pasteurellaceae | 454 sequencing, V3-V5 region | 153 (Switzerland) | 0–24 | 60 | |
Nasal swabs | S. pneumoniae, H. influenzae, M. catarrhalis | 454 sequencing, V1-V2 region | 240 (USA) | 3–36 | 15 | |
MEF aspirates | S. pneumoniae, H. influenzae, M. catarrhalis, T. otitidis, S. auricularis | Illumina MiSeq, V4 region | 79 (Finland) | 5–42 | 61 | |
Nasal swabs | Moraxella, Haemophilus, Streptococcus | Illumina MiSeq, V4 region | 139 (USA) | 1–12 | 282 | |
MEF aspirates, middle ear aspirates, ear canal swabs, nasal swabs | Haemophilus, Turicella, Alloiococcus, Staphylococcus | Illumina MiSeq, V3-V4 region | 196 (Australia) | 0–60 | 64 | |
OME | MEF aspirates, adenoid and tonsil tissue samples | Pseudomonadaceae, Streptococcaceae, Fusobacteriaceae, Pasteurellaceae | 454 sequencing, V3-V4 region | 1 (USA) | 96 | 65 |
MEF aspirates, adenoid swabs, nasal swabs | Alloiococcus, Haemophilus, Streptococcus, Moraxella | Illumina MiSeq, V1-V3 region | 11 (Australia) | 3–10 yrs | 66 | |
MEF aspirates, adenoid swabs | Alloiococcus, Haemophilus, Moraxella, Staphylococcus, Streptococcus, Pseudomonas, Corynebacterium | Illumina MiSeq, V3-V4 region | 18 (Australia) | 1–16 yrs | 67, 68 | |
Middle ear, adenoid, and tonsil swabs | Fusobacterium, Haemophilus, Neisseria, Porphyromonas | Illumina MiSeq, V3-V4 region | 10 (New Zealand) | 2–10 yrs | 70 | |
COM | Middle ear swabs, mastoid swabs | Haemophilus, Staphylococcus, Alloiococcus | Illumina MiSeq, V3-V4 region | 46 (New Zealand) | 6 mos–87 yrs | 72 |
MEF aspirates | Haemophilus, Moraxella, Turicella | Illumina MiSeq, V4 region | 55 (USA) | 0–24, 25 subjects; >24, 30 subjects | 71 |
Bacteria were significantly more abundant in this group, as indicated by the authors.